These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1069 related items for PubMed ID: 21199526
1. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. Kew MC. J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526 [Abstract] [Full Text] [Related]
2. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC. Oncogene; 2001 Jun 21; 20(28):3620-8. PubMed ID: 11439325 [Abstract] [Full Text] [Related]
3. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis. Zhu R, Mok MT, Kang W, Lau SS, Yip WK, Chen Y, Lai PB, Wong VW, To KF, Sung JJ, Cheng AS, Chan HL. J Pathol; 2015 Sep 21; 237(1):38-49. PubMed ID: 25925944 [Abstract] [Full Text] [Related]
4. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, Qiu G, Xie K. Int J Oncol; 2005 Feb 21; 26(2):467-73. PubMed ID: 15645132 [Abstract] [Full Text] [Related]
5. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma. Kim DG. Methods Mol Biol; 2006 Feb 21; 317():141-55. PubMed ID: 16264227 [Abstract] [Full Text] [Related]
6. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI. Gastroenterology; 2007 Apr 21; 132(4):1476-94. PubMed ID: 17408664 [Abstract] [Full Text] [Related]
7. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY. Clin Cancer Res; 2008 Aug 15; 14(16):5061-8. PubMed ID: 18698024 [Abstract] [Full Text] [Related]
8. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D. Cancer Res; 2001 Nov 01; 61(21):7803-10. PubMed ID: 11691796 [Abstract] [Full Text] [Related]
9. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C. Oncogene; 1999 Aug 26; 18(34):4848-59. PubMed ID: 10490818 [Abstract] [Full Text] [Related]
10. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector]. Joo HY, Han KH, Ryu WS. Taehan Kan Hakhoe Chi; 2002 Dec 26; 8(4):371-80. PubMed ID: 12506241 [Abstract] [Full Text] [Related]
11. Hepatitis B virus-induced hepatocellular carcinoma. Xu C, Zhou W, Wang Y, Qiao L. Cancer Lett; 2014 Apr 10; 345(2):216-22. PubMed ID: 23981576 [Abstract] [Full Text] [Related]
12. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism]. Liu KG, Shao XL, Xie HH, Xu L, Zhao H, Guo ZH, Li L, Liu J. Zhonghua Gan Zang Bing Za Zhi; 2010 Nov 10; 18(11):831-6. PubMed ID: 21138631 [Abstract] [Full Text] [Related]
13. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH, Harris CC. Cancer Res; 1995 Dec 15; 55(24):6012-6. PubMed ID: 8521383 [Abstract] [Full Text] [Related]
14. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M. J Exp Clin Cancer Res; 1999 Sep 15; 18(3):379-89. PubMed ID: 10606185 [Abstract] [Full Text] [Related]
15. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation. Jung JK, Park SH, Jang KL. J Gen Virol; 2010 Feb 15; 91(Pt 2):493-500. PubMed ID: 19828754 [Abstract] [Full Text] [Related]
16. Distinctive gene expression profiles associated with Hepatitis B virus x protein. Wu CG, Salvay DM, Forgues M, Valerie K, Farnsworth J, Markin RS, Wang XW. Oncogene; 2001 Jun 21; 20(28):3674-82. PubMed ID: 11439330 [Abstract] [Full Text] [Related]
17. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. Chan DW, Ng IO. J Pathol; 2006 Feb 21; 208(3):372-80. PubMed ID: 16353167 [Abstract] [Full Text] [Related]
18. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D. Mol Carcinog; 2009 Jan 21; 48(1):56-65. PubMed ID: 18506760 [Abstract] [Full Text] [Related]
19. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH, Lee YS, Jang KL, Kim CH, Johnston RN, Chung YH. Cancer Gene Ther; 2009 May 21; 16(5):453-61. PubMed ID: 19096445 [Abstract] [Full Text] [Related]
20. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. Chen GG, Li MY, Ho RL, Chak EC, Lau WY, Lai PB. J Clin Virol; 2005 Sep 21; 34(1):7-12. PubMed ID: 16087118 [Abstract] [Full Text] [Related] Page: [Next] [New Search]